<?xml version="1.0"  ?><!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd"><pmc-articleset><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" article-type="research-article" xml:lang="en" dtd-version="1.4"><front><journal-meta><journal-id journal-id-type="nlm-ta">Cytometry A</journal-id><journal-id journal-id-type="iso-abbrev">Cytometry A</journal-id><journal-id journal-id-type="pmc-domain-id">379</journal-id><journal-id journal-id-type="pmc-domain">blackwellopen</journal-id><journal-id journal-id-type="publisher-id">CYTO</journal-id><journal-title-group><journal-title>Cytometry</journal-title></journal-title-group><issn pub-type="ppub">1552-4922</issn><issn pub-type="epub">1552-4930</issn><custom-meta-group><custom-meta><meta-name>pmc-is-collection-domain</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-collection-title</meta-name><meta-value>Wiley Open Access Collection</meta-value></custom-meta></custom-meta-group></journal-meta><article-meta><article-id pub-id-type="pmcid">PMC6590190</article-id><article-id pub-id-type="pmcid-ver">PMC6590190.1</article-id><article-id pub-id-type="pmcaid">6590190</article-id><article-id pub-id-type="pmcaiid">6590190</article-id><article-id pub-id-type="pmid">30701669</article-id><article-id pub-id-type="doi">10.1002/cyto.a.23725</article-id><article-id pub-id-type="publisher-id">CYTOA23725</article-id><article-version article-version-type="pmc-version">1</article-version><article-categories><subj-group subj-group-type="overline"><subject>Omip</subject></subj-group><subj-group subj-group-type="heading"><subject>Omip</subject></subj-group></article-categories><title-group><article-title>OMIP&#8208;054: Broad Immune Phenotyping of Innate and Adaptive Leukocytes in the Brain, Spleen, and Bone Marrow of an Orthotopic Murine Glioblastoma Model by Mass Cytometry</article-title><alt-title alt-title-type="right-running-head">Broad immune phenotyping in murine glioblastoma</alt-title></title-group><contrib-group><contrib id="cytoa23725-cr-0001" contrib-type="author"><name name-style="western"><surname>Dusoswa</surname><given-names initials="SA">Sophie A.</given-names></name><xref ref-type="aff" rid="cytoa23725-aff-0001">
<sup>1</sup>
</xref></contrib><contrib id="cytoa23725-cr-0002" contrib-type="author"><name name-style="western"><surname>Verhoeff</surname><given-names initials="J">Jan</given-names></name><xref ref-type="aff" rid="cytoa23725-aff-0001">
<sup>1</sup>
</xref></contrib><contrib id="cytoa23725-cr-0003" contrib-type="author" corresp="yes"><name name-style="western"><surname>Garcia&#8208;Vallejo</surname><given-names initials="JJ">Juan J.</given-names></name><contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0001-6238-7069</contrib-id><address><email>jj.garciavallejo@vumc.nl</email></address><xref ref-type="aff" rid="cytoa23725-aff-0001">
<sup>1</sup>
</xref></contrib></contrib-group><aff id="cytoa23725-aff-0001">
<label><sup>1</sup></label>
<named-content content-type="organisation-division">Amsterdam UMC, Vrije Universiteit Amsterdam, Department of Molecular Cell Biology &amp; Immunology</named-content>
<institution>Amsterdam Infection &amp; Immunity Institute and Cancer Center Amsterdam</institution>
<named-content content-type="city">Amsterdam</named-content>
<country country="NL">The Netherlands</country>
</aff><author-notes><corresp id="correspondenceTo"><label>*</label>Correspondence to: Dr. Juan J. Garcia Vallejo, Amsterdam UMC, Vrije Universiteit Amsterdam, Department of Molecular Cell Biology &amp; Immunology, Amsterdam Infection &amp; Immunity Institute and Cancer Center Amsterdam, de Boelelaan 1108, Amsterdam 1081 HZ, The Netherlands. Email: <email>jj.garciavallejo@vumc.nl</email></corresp></author-notes><pub-date pub-type="epub"><day>31</day><month>1</month><year>2019</year></pub-date><pub-date pub-type="ppub"><month>4</month><year>2019</year></pub-date><volume>95</volume><issue>4</issue><issue-id pub-id-type="pmc-issue-id">337008</issue-id><issue-id pub-id-type="doi">10.1002/cyto.a.v95.4</issue-id><issue-title content-type="special-issue-title">Image Cytometry</issue-title><fpage>422</fpage><lpage>426</lpage><history><date date-type="received"><day>02</day><month>8</month><year>2018</year></date><date date-type="rev-recd"><day>10</day><month>1</month><year>2019</year></date><date date-type="accepted"><day>14</day><month>1</month><year>2019</year></date></history><pub-history><event event-type="pmc-release"><date><day>24</day><month>06</month><year>2019</year></date></event><event event-type="pmc-live"><date><day>08</day><month>07</month><year>2019</year></date></event><event event-type="pmc-last-change"><date iso-8601-date="2019-07-09 00:19:24.217"><day>09</day><month>07</month><year>2019</year></date></event></pub-history><permissions><copyright-statement content-type="article-copyright">&#169; 2019 The Authors. <italic toggle="yes">Cytometry Part A</italic> published by Wiley Periodicals, Inc. on behalf of International Society for Advancement of Cytometry.</copyright-statement><license license-type="creativeCommonsBy-nc-nd"><ali:license_ref specific-use="textmining" content-type="ccbyncndlicense">https://creativecommons.org/licenses/by-nc-nd/4.0/</ali:license_ref><license-p>This is an open access article under the terms of the <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by-nc-nd/4.0/">http://creativecommons.org/licenses/by-nc-nd/4.0/</ext-link> License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non&#8208;commercial and no modifications or adaptations are made.</license-p></license></permissions><self-uri xmlns:xlink="http://www.w3.org/1999/xlink" content-type="pmc-pdf" xlink:href="CYTO-95-422.pdf"/><self-uri xmlns:xlink="http://www.w3.org/1999/xlink" content-type="pdf" xlink:href="file:CYTO-95-422.pdf"/><abstract abstract-type="short"><p>
<inline-graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:title="MIFlowCyt compliant" xlink:href="CYTO-95-422-g002.jpg"/>
</p></abstract><funding-group><award-group><funding-source>Cancer Center Amsterdam, the Netherlands</funding-source></award-group><award-group><funding-source>Institute Chemical Immunology, the Netherlands</funding-source></award-group></funding-group><counts><fig-count count="1"/><table-count count="2"/><page-count count="5"/><word-count count="2897"/></counts><custom-meta-group><custom-meta><meta-name>pmc-status-qastatus</meta-name><meta-value>0</meta-value></custom-meta><custom-meta><meta-name>pmc-status-live</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-status-embargo</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-status-released</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-open-access</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-olf</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-manuscript</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-legally-suppressed</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-pdf</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-supplement</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-pdf-only</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-suppress-copyright</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-real-version</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-scanned-article</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-preprint</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-in-epmc</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-license-ref</meta-name><meta-value>CC BY-NC-ND</meta-value></custom-meta><custom-meta><meta-name>source-schema-version-number</meta-name><meta-value>2.0</meta-value></custom-meta><custom-meta><meta-name>component-id</meta-name><meta-value>cytoa23725</meta-value></custom-meta><custom-meta><meta-name>cover-date</meta-name><meta-value>April 2019</meta-value></custom-meta><custom-meta><meta-name>details-of-publishers-convertor</meta-name><meta-value>Converter:WILEY_ML3GV2_TO_NLMPMC version:5.6.4 mode:remove_FC converted:24.06.2019</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec id="cytoa23725-sec-0001"><title>Purpose and Appropriate Sample Types</title><p>Here we present a 42 parameter panel to characterize myeloid immune cell subsets and T lymphocyte activation status in cryopreserved and barcoded single cell suspensions obtained from brain, spleen, and bone marrow of an orthotopic immunocompetent glioblastoma mouse model in a C57BL/6 background (Table <xref rid="cytoa23725-tbl-0001" ref-type="table">1</xref>). This panel is designed for mass cytometry by time of flight (CyTOF) and combines 34 antibodies against diverse cell surface and intracellular targets together with cisplatin for live/dead discrimination, iridium for cell identification, and six cellular barcodes <xref rid="cytoa23725-bib-0001" ref-type="ref">1</xref> to enable simultaneous multiplexed acquisition of up to 20 samples (Table <xref rid="cytoa23725-tbl-0002" ref-type="table">2</xref>). The panel is designed for a comprehensive evaluation of the immune system in different organs during murine in vivo studies in the field of glioblastoma immunology, but could also be applied to other disease models in the central nervous system (CNS) with possible systemic involvement, such as brain metastasis arising from other types of cancer, experimental autoimmune encephalomyelitis (EAE), or neurodegenerative disease models. Marker selection was partly based on a combination of previously reported panels studying CNS immune infiltrates <xref rid="cytoa23725-bib-0002" ref-type="ref">2</xref>, <xref rid="cytoa23725-bib-0003" ref-type="ref">3</xref>, <xref rid="cytoa23725-bib-0004" ref-type="ref">4</xref>, <xref rid="cytoa23725-bib-0005" ref-type="ref">5</xref>, <xref rid="cytoa23725-bib-0006" ref-type="ref">6</xref>, <xref rid="cytoa23725-bib-0007" ref-type="ref">7</xref>. The selected set of markers captures T lymphocytes (CD8+, CD4+, and regulatory T lymphocytes), dendritic cells (DC), monocytes, macrophages, microglia, tumor cells (when GFP positive), and granulocytes, and contains a set of antibodies to detect cell activation, migratory capacity and immune checkpoints (Table <xref rid="cytoa23725-tbl-0002" ref-type="table">2</xref>). The panel has been optimized with respect to marker selection, antibody clone usage, antibody&#8208;metal pairing, and antibody concentration, and has room for additional markers by filling in a number of free channels as listed in Table <xref rid="cytoa23725-tbl-0002" ref-type="table">2</xref>.</p><table-wrap id="cytoa23725-tbl-0001" xml:lang="en" orientation="portrait" position="float"><label>Table 1</label><caption><p>Summary table for the application of this OMIP</p></caption><table frame="hsides" rules="cols"><col align="left" span="1"/><col align="left" span="1"/><thead valign="bottom"><tr style="border-bottom:solid 1px #000000"><th align="left" valign="bottom" rowspan="1" colspan="1">Purpose</th><th align="center" valign="bottom" rowspan="1" colspan="1">Immunophenotyping of innate and adaptive immune cells in a murine glioblastoma model</th></tr></thead><tbody valign="top"><tr><td align="left" valign="top" rowspan="1" colspan="1">Species</td><td align="left" valign="top" rowspan="1" colspan="1">Mouse</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Cell types</td><td align="left" valign="top" rowspan="1" colspan="1">Single cells from Miltenyi neural tissue dissociation kit (P) treated brain</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Cross&#8208;references</td><td align="left" valign="top" rowspan="1" colspan="1">No similar OMIP</td></tr></tbody></table></table-wrap><table-wrap id="cytoa23725-tbl-0002" xml:lang="en" orientation="portrait" position="float"><label>Table 2</label><caption><p>Summary table for the antibodies in this panel</p></caption><table frame="hsides" rules="cols"><col align="left" span="1"/><col align="left" span="1"/><col align="left" span="1"/><col align="left" span="1"/><col align="left" span="1"/><thead valign="bottom"><tr style="border-bottom:solid 1px #000000"><th align="left" valign="bottom" rowspan="1" colspan="1">Target protein</th><th align="left" valign="bottom" rowspan="1" colspan="1">Clone</th><th align="left" valign="bottom" rowspan="1" colspan="1">Metal</th><th align="left" valign="bottom" rowspan="1" colspan="1">Source</th><th align="left" valign="bottom" rowspan="1" colspan="1">Purpose</th></tr></thead><tbody valign="top"><tr><td align="left" valign="top" rowspan="1" colspan="1">Cell identification</td><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/></tr><tr><td style="padding-left:10%" align="left" valign="top" rowspan="1" colspan="1">Barcodes</td><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1">103&#8211;110Pd</td><td align="left" valign="top" rowspan="1" colspan="1">Fluidigm</td><td align="left" valign="top" rowspan="1" colspan="1">Staining standardization and doublet discrimination</td></tr><tr><td style="padding-left:10%" align="left" valign="top" rowspan="1" colspan="1">Iridium</td><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1">191&#8211;193Ir</td><td align="left" valign="top" rowspan="1" colspan="1">Fluidigm</td><td align="left" valign="top" rowspan="1" colspan="1">Cell identification</td></tr><tr><td style="padding-left:10%" align="left" valign="top" rowspan="1" colspan="1">Cisplatin</td><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1">194&#8211;195Pt</td><td align="left" valign="top" rowspan="1" colspan="1">Fluidigm</td><td align="left" valign="top" rowspan="1" colspan="1">Live/dead discrimination</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Cell classification</td><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/></tr><tr><td style="padding-left:10%" align="left" valign="top" rowspan="1" colspan="1">CD45</td><td align="left" valign="top" rowspan="1" colspan="1">30&#8208;F11</td><td align="left" valign="top" rowspan="1" colspan="1">89Y</td><td align="left" valign="top" rowspan="1" colspan="1">Fluidigm</td><td align="left" valign="top" rowspan="1" colspan="1">All leukocytes</td></tr><tr><td style="padding-left:10%" align="left" valign="top" rowspan="1" colspan="1">CD3e</td><td align="left" valign="top" rowspan="1" colspan="1">145&#8208;2C11</td><td align="left" valign="top" rowspan="1" colspan="1">152Sm</td><td align="left" valign="top" rowspan="1" colspan="1">Fluidigm</td><td align="left" valign="top" rowspan="1" colspan="1">T lymphocytes</td></tr><tr><td style="padding-left:10%" align="left" valign="top" rowspan="1" colspan="1">TCRb</td><td align="left" valign="top" rowspan="1" colspan="1">H57&#8208;597</td><td align="left" valign="top" rowspan="1" colspan="1">169Tm</td><td align="left" valign="top" rowspan="1" colspan="1">Fluidigm</td><td align="left" valign="top" rowspan="1" colspan="1">T a/b lymphocyte receptor</td></tr><tr><td style="padding-left:10%" align="left" valign="top" rowspan="1" colspan="1">CD4</td><td align="left" valign="top" rowspan="1" colspan="1">RM4&#8208;5</td><td align="left" valign="top" rowspan="1" colspan="1">145Nd</td><td align="left" valign="top" rowspan="1" colspan="1">Fluidigm</td><td align="left" valign="top" rowspan="1" colspan="1">T helper lymphocytes</td></tr><tr><td style="padding-left:10%" align="left" valign="top" rowspan="1" colspan="1">Foxp3 (FJK16s)</td><td align="left" valign="top" rowspan="1" colspan="1">FJK&#8208;16s</td><td align="left" valign="top" rowspan="1" colspan="1">158Gd</td><td align="left" valign="top" rowspan="1" colspan="1">Fluidigm</td><td align="left" valign="top" rowspan="1" colspan="1">Regulatory T lymphocytes</td></tr><tr><td style="padding-left:10%" align="left" valign="top" rowspan="1" colspan="1">CD8b</td><td align="left" valign="top" rowspan="1" colspan="1">536.7</td><td align="left" valign="top" rowspan="1" colspan="1">168Er</td><td align="left" valign="top" rowspan="1" colspan="1">Fluidigm</td><td align="left" valign="top" rowspan="1" colspan="1">Cytotoxic T lymphocytes</td></tr><tr><td style="padding-left:10%" align="left" valign="top" rowspan="1" colspan="1">CD127 (IL&#8208;7Ra)</td><td align="left" valign="top" rowspan="1" colspan="1">A7R34</td><td align="left" valign="top" rowspan="1" colspan="1">175Lu</td><td align="left" valign="top" rowspan="1" colspan="1">Fluidigm</td><td align="left" valign="top" rowspan="1" colspan="1">Memory T lymphocytes</td></tr><tr><td style="padding-left:10%" align="left" valign="top" rowspan="1" colspan="1">CD28</td><td align="left" valign="top" rowspan="1" colspan="1">37.51</td><td align="left" valign="top" rowspan="1" colspan="1">151Eu</td><td align="left" valign="top" rowspan="1" colspan="1">Fluidigm</td><td align="left" valign="top" rowspan="1" colspan="1">T lymphocytes, natural killer cells</td></tr><tr><td style="padding-left:10%" align="left" valign="top" rowspan="1" colspan="1">Ly&#8208;6G</td><td align="left" valign="top" rowspan="1" colspan="1">1A8</td><td align="left" valign="top" rowspan="1" colspan="1">141Pr</td><td align="left" valign="top" rowspan="1" colspan="1">Fluidigm</td><td align="left" valign="top" rowspan="1" colspan="1">Granulocytes</td></tr><tr><td style="padding-left:10%" align="left" valign="top" rowspan="1" colspan="1">Ly&#8208;6C</td><td align="left" valign="top" rowspan="1" colspan="1">HK1.4</td><td align="left" valign="top" rowspan="1" colspan="1">150Nd</td><td align="left" valign="top" rowspan="1" colspan="1">Fluidigm</td><td align="left" valign="top" rowspan="1" colspan="1">Monocytes, macrophages</td></tr><tr><td style="padding-left:10%" align="left" valign="top" rowspan="1" colspan="1">CD11b (Mac&#8208;1)</td><td align="left" valign="top" rowspan="1" colspan="1">M1/70</td><td align="left" valign="top" rowspan="1" colspan="1">148Nd</td><td align="left" valign="top" rowspan="1" colspan="1">Fluidigm</td><td align="left" valign="top" rowspan="1" colspan="1">Macrophages, microglia, dendritic cells, granulocytes</td></tr><tr><td style="padding-left:10%" align="left" valign="top" rowspan="1" colspan="1">CD11c</td><td align="left" valign="top" rowspan="1" colspan="1">N418</td><td align="left" valign="top" rowspan="1" colspan="1">209Bi</td><td align="left" valign="top" rowspan="1" colspan="1">Fluidigm</td><td align="left" valign="top" rowspan="1" colspan="1">Dendritic cells</td></tr><tr><td style="padding-left:10%" align="left" valign="top" rowspan="1" colspan="1">CD14</td><td align="left" valign="top" rowspan="1" colspan="1">Sa14&#8208;2</td><td align="left" valign="top" rowspan="1" colspan="1">144Nd</td><td align="left" valign="top" rowspan="1" colspan="1">Biolegend</td><td align="left" valign="top" rowspan="1" colspan="1">Monocytes</td></tr><tr><td style="padding-left:10%" align="left" valign="top" rowspan="1" colspan="1">CD88</td><td align="left" valign="top" rowspan="1" colspan="1">20/70</td><td align="left" valign="top" rowspan="1" colspan="1">161Dy</td><td align="left" valign="top" rowspan="1" colspan="1">Biolegend</td><td align="left" valign="top" rowspan="1" colspan="1">Monocytes, macrophages, neutrophils, eosinophils</td></tr><tr><td style="padding-left:10%" align="left" valign="top" rowspan="1" colspan="1">MHC class 2 I&#8208;A/I&#8208;E</td><td align="left" valign="top" rowspan="1" colspan="1">M5/114.15.2</td><td align="left" valign="top" rowspan="1" colspan="1">174Yb</td><td align="left" valign="top" rowspan="1" colspan="1">Fluidigm</td><td align="left" valign="top" rowspan="1" colspan="1">Antigen presenting cells, T lymphocyte activation?</td></tr><tr><td style="padding-left:10%" align="left" valign="top" rowspan="1" colspan="1">TMEM119</td><td align="left" valign="top" rowspan="1" colspan="1">106&#8211;6</td><td align="left" valign="top" rowspan="1" colspan="1">146Nd</td><td align="left" valign="top" rowspan="1" colspan="1">Abcam</td><td align="left" valign="top" rowspan="1" colspan="1">Microglia</td></tr><tr><td style="padding-left:10%" align="left" valign="top" rowspan="1" colspan="1">CD49d</td><td align="left" valign="top" rowspan="1" colspan="1">R1&#8208;2</td><td align="left" valign="top" rowspan="1" colspan="1">176Yb</td><td align="left" valign="top" rowspan="1" colspan="1">Biolegend</td><td align="left" valign="top" rowspan="1" colspan="1">Exclusion marker for microglia</td></tr><tr><td style="padding-left:10%" align="left" valign="top" rowspan="1" colspan="1">CD169 (Siglec&#8208;1)</td><td align="left" valign="top" rowspan="1" colspan="1">3D6.112</td><td align="left" valign="top" rowspan="1" colspan="1">142Nd</td><td align="left" valign="top" rowspan="1" colspan="1">Biolegend</td><td align="left" valign="top" rowspan="1" colspan="1">Dendritic cells, macrophages, microglia</td></tr><tr><td style="padding-left:10%" align="left" valign="top" rowspan="1" colspan="1">CD206 (Mannose receptor)</td><td align="left" valign="top" rowspan="1" colspan="1">C068C2</td><td align="left" valign="top" rowspan="1" colspan="1">160Gd</td><td align="left" valign="top" rowspan="1" colspan="1">Biolegend</td><td align="left" valign="top" rowspan="1" colspan="1">Macrophages, dendritic cells</td></tr><tr><td style="padding-left:10%" align="left" valign="top" rowspan="1" colspan="1">Siglec H</td><td align="left" valign="top" rowspan="1" colspan="1">440c</td><td align="left" valign="top" rowspan="1" colspan="1">166Er</td><td align="left" valign="top" rowspan="1" colspan="1">Genetex</td><td align="left" valign="top" rowspan="1" colspan="1">Plasmacytoid dendritic cells, Microglia</td></tr><tr><td style="padding-left:10%" align="left" valign="top" rowspan="1" colspan="1">CD38</td><td align="left" valign="top" rowspan="1" colspan="1">90</td><td align="left" valign="top" rowspan="1" colspan="1">153Eu</td><td align="left" valign="top" rowspan="1" colspan="1">Biolegend</td><td align="left" valign="top" rowspan="1" colspan="1">B lymphocyte (pre&#8208;cursors), macrophages</td></tr><tr><td style="padding-left:10%" align="left" valign="top" rowspan="1" colspan="1">aGFP</td><td align="left" valign="top" rowspan="1" colspan="1">454,505</td><td align="left" valign="top" rowspan="1" colspan="1">173Yb</td><td align="left" valign="top" rowspan="1" colspan="1">Biolegend</td><td align="left" valign="top" rowspan="1" colspan="1">Tumor cells</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Migration</td><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/></tr><tr><td style="padding-left:10%" align="left" valign="top" rowspan="1" colspan="1">CCR2</td><td align="left" valign="top" rowspan="1" colspan="1">475,301</td><td align="left" valign="top" rowspan="1" colspan="1">165Ho</td><td align="left" valign="top" rowspan="1" colspan="1">RnD systems</td><td align="left" valign="top" rowspan="1" colspan="1">Monocyte chemotaxis</td></tr><tr><td style="padding-left:10%" align="left" valign="top" rowspan="1" colspan="1">CCR6</td><td align="left" valign="top" rowspan="1" colspan="1">29&#8208;2L17</td><td align="left" valign="top" rowspan="1" colspan="1">156Gd</td><td align="left" valign="top" rowspan="1" colspan="1">Fluidigm</td><td align="left" valign="top" rowspan="1" colspan="1">Dendritic cell&#8208; and lymphocyte chemotaxis</td></tr><tr><td style="padding-left:10%" align="left" valign="top" rowspan="1" colspan="1">CD54 (ICAM&#8208;1)</td><td align="left" valign="top" rowspan="1" colspan="1">YN1/1.7.4</td><td align="left" valign="top" rowspan="1" colspan="1">163Dy</td><td align="left" valign="top" rowspan="1" colspan="1">Fluidigm</td><td align="left" valign="top" rowspan="1" colspan="1">Leukocyte extravasation</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Activation</td><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/></tr><tr><td style="padding-left:10%" align="left" valign="top" rowspan="1" colspan="1">Ly&#8208;6A/E (Sca&#8208;1)</td><td align="left" valign="top" rowspan="1" colspan="1">D7</td><td align="left" valign="top" rowspan="1" colspan="1">164Dy</td><td align="left" valign="top" rowspan="1" colspan="1">Fluidigm</td><td align="left" valign="top" rowspan="1" colspan="1">Hematopoietic stem cell marker/ activation of lymphocytes</td></tr><tr><td style="padding-left:10%" align="left" valign="top" rowspan="1" colspan="1">Ki&#8208;67</td><td align="left" valign="top" rowspan="1" colspan="1">B56</td><td align="left" valign="top" rowspan="1" colspan="1">172Yb</td><td align="left" valign="top" rowspan="1" colspan="1">Fluidigm</td><td align="left" valign="top" rowspan="1" colspan="1">Cell proliferation</td></tr><tr><td style="padding-left:10%" align="left" valign="top" rowspan="1" colspan="1">CD69</td><td align="left" valign="top" rowspan="1" colspan="1">H1.2F3</td><td align="left" valign="top" rowspan="1" colspan="1">143Nd</td><td align="left" valign="top" rowspan="1" colspan="1">Fluidigm</td><td align="left" valign="top" rowspan="1" colspan="1">Activated T lymphocytes</td></tr><tr><td style="padding-left:10%" align="left" valign="top" rowspan="1" colspan="1">CD44</td><td align="left" valign="top" rowspan="1" colspan="1">IM7</td><td align="left" valign="top" rowspan="1" colspan="1">171Yb</td><td align="left" valign="top" rowspan="1" colspan="1">Fluidigm</td><td align="left" valign="top" rowspan="1" colspan="1">Activated lymphocytes</td></tr><tr><td style="padding-left:10%" align="left" valign="top" rowspan="1" colspan="1">CD150 (SLAM, IPO&#8208;3)</td><td align="left" valign="top" rowspan="1" colspan="1">TC15&#8208;12F12.2</td><td align="left" valign="top" rowspan="1" colspan="1">167Er</td><td align="left" valign="top" rowspan="1" colspan="1">Fluidigm</td><td align="left" valign="top" rowspan="1" colspan="1">Activated lymphocytes and dendritic cells</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Immune checkpoints</td><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/></tr><tr><td style="padding-left:10%" align="left" valign="top" rowspan="1" colspan="1">CD152 (CTLA&#8208;4)</td><td align="left" valign="top" rowspan="1" colspan="1">UC10&#8208;4B9</td><td align="left" valign="top" rowspan="1" colspan="1">154Sm</td><td align="left" valign="top" rowspan="1" colspan="1">Fluidigm</td><td align="left" valign="top" rowspan="1" colspan="1">Co&#8208;inhibitory molecule</td></tr><tr><td style="padding-left:10%" align="left" valign="top" rowspan="1" colspan="1">CD279 (PD&#8208;1)</td><td align="left" valign="top" rowspan="1" colspan="1">J43</td><td align="left" valign="top" rowspan="1" colspan="1">159Tb</td><td align="left" valign="top" rowspan="1" colspan="1">Fluidigm</td><td align="left" valign="top" rowspan="1" colspan="1">Co&#8208;inhibitory molecule</td></tr><tr><td style="padding-left:10%" align="left" valign="top" rowspan="1" colspan="1">CD274 (PD&#8208;L1)</td><td align="left" valign="top" rowspan="1" colspan="1">10F.9G2</td><td align="left" valign="top" rowspan="1" colspan="1">155Gd</td><td align="left" valign="top" rowspan="1" colspan="1">Biolegend</td><td align="left" valign="top" rowspan="1" colspan="1">PD1 ligand</td></tr><tr><td style="padding-left:10%" align="left" valign="top" rowspan="1" colspan="1">CD366 (Tim&#8208;3)</td><td align="left" valign="top" rowspan="1" colspan="1">RMT3&#8208;23</td><td align="left" valign="top" rowspan="1" colspan="1">162Dy</td><td align="left" valign="top" rowspan="1" colspan="1">Fluidigm</td><td align="left" valign="top" rowspan="1" colspan="1">Co&#8208;inhibitory molecule</td></tr><tr><td style="padding-left:10%" align="left" valign="top" rowspan="1" colspan="1">Free channels</td><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/></tr><tr><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1">113&#8211;115In</td><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/></tr><tr><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1">147Sm</td><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/></tr><tr><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1">149Sm</td><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/></tr><tr><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1">170Er</td><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/></tr></tbody></table></table-wrap></sec><sec id="cytoa23725-sec-0002"><title>Background</title><p>In the last decades enormous efforts have been made to develop therapeutic interventions that boost antitumor immunity, including adoptive cell transfer, anti&#8208;cancer vaccination, application of oncolytic viruses, and immune checkpoint inhibition <xref rid="cytoa23725-bib-0008" ref-type="ref">8</xref>, <xref rid="cytoa23725-bib-0009" ref-type="ref">9</xref>. A wide range of immunotherapeutic strategies are being tested in glioblastoma, advanced by successes in other tumor types. In these approaches particularly T cells are targeted as final effector cells by, for example, dendritic cell vaccination or immune checkpoint inhibition, but durable responses remain limited to case reports <xref rid="cytoa23725-bib-0010" ref-type="ref">10</xref>. Boosted T cell responses as a result of, for example, vaccination strategies encounter functional impairment due to immune inhibitory mechanisms both in the tumor microenvironment and systemically. To overcome T cell inhibition hope was pinned on immune checkpoint inhibition with monoclonal antibody therapy against PD1 and CTLA&#8208;4. Nevertheless, to date clinical trials testing immune checkpoint inhibition in glioblastoma have not shown impressive results <xref rid="cytoa23725-bib-0011" ref-type="ref">11</xref>. Clearly glioblastoma&#8208;specific immune suppression is a complex and unsolved problem that remains an obstacle for successful immunotherapies. Therefore, a better understanding of glioblastoma immune escape and contributing factors is warranted, alongside the development of biomarkers for patient selection and prediction of clinical response. Immune suppression in glioblastoma is largely mediated by infiltration of monocytes into the glioblastoma microenvironment <xref rid="cytoa23725-bib-0012" ref-type="ref">12</xref>. Myeloid immune cells dominate immune infiltrates and are involved in glioblastoma disease progression <xref rid="cytoa23725-bib-0013" ref-type="ref">13</xref>, <xref rid="cytoa23725-bib-0014" ref-type="ref">14</xref>, <xref rid="cytoa23725-bib-0015" ref-type="ref">15</xref>. Although some subsets have been studied in isolation, the different types of infiltrating myeloid and lymphoid cells, their recruitment from the bone marrow and spleen, and their phenotypic distribution need further investigation.</p><p>Mass cytometry provides for the simultaneous measurement of more than 40 parameters at single cell resolution, improving the ability of cytometry to characterize the complexity of the immune system <xref rid="cytoa23725-bib-0016" ref-type="ref">16</xref>. Similar to the development of antibody panels for multichromatic fluorescence cytometry, mass cytometry panel development requires optimization of antibody&#8208;metal pairing, conjugation of antibodies with metal polymers, determination of optimal antibody concentrations, and optimization of buffers and staining conditions. Here we developed a mass cytometry immunophenotyping panel, which was designed to quantify population frequencies and to infer functional states of T cells, including activation, differentiation, exhaustion, or anergy in the murine glioblastoma microenvironment (Fig. <xref rid="cytoa23725-fig-0001" ref-type="fig">1</xref>) and spleen. Furthermore, our panel helps to differentiate and quantify a multitude of glioblastoma infiltrating and bone marrow derived myeloid cell subsets and immune cells resident to the bone marrow. Although this panel is optimized for single cell suspensions obtained from mouse brain, spleen, and bone marrow it could also be applied to the study of innate and adaptive components of the immune system in other mouse organs. Single cell suspensions were generated using mechanical dissociation and enzymatic digestion using the Neural Tissue Dissociation kit P (Miltenyi, Germany) <xref rid="cytoa23725-bib-0017" ref-type="ref">17</xref>. After live/dead staining and barcoding <xref rid="cytoa23725-bib-0001" ref-type="ref">1</xref> cells were cryopreserved until antibody staining and mass cytometry analysis (Fig. <xref rid="cytoa23725-fig-0001" ref-type="fig">1</xref>A). Following data pre&#8208;processing including bead normalization <xref rid="cytoa23725-bib-0018" ref-type="ref">18</xref> and debarcoding <xref rid="cytoa23725-bib-0001" ref-type="ref">1</xref>, the first gates aimed at exclusion of normalization beads, cell debris, doublets, and dead cells (<sup>140</sup>Ce<sup>&#8722;</sup>, <sup>193</sup>Ir<sup>+</sup>, and <sup>194</sup>Pt<sup>&#8722;</sup>). Next, we plotted CD45 against CD11c to identify CD45<sup>hi</sup>CD11c<sup>hi</sup> DCs (population 1). Plotting CD45 against CD11b for non&#8208;DCs resulted in four main populations: CD45<sup>&#8722;</sup> non&#8208;immune cells (population 2), CD45<sup>+</sup>CD11b<sup>&#8722;</sup> lymphocytes, CD45<sup>+</sup>CD11b<sup>+</sup> infiltrating myeloid cells, and CD45<sup>dim</sup>CD11b<sup>+</sup> microglia. CD45<sup>&#8722;</sup> cells include tumor cells and non&#8208;immune non&#8208;tumor brain resident cells, such as glial cells or neurons. In the CD45<sup>+</sup>CD11b<sup>&#8722;</sup>CD3<sup>+</sup>TCRb<sup>+</sup> cells we identified CD8<sup>+</sup> T cells, CD4<sup>+</sup> T cells, and CD4<sup>+</sup>FoxP3<sup>+</sup> regulatory T cells (populations 3, 4, and 5, respectively). Next, we identified microglia as being the CD44<sup>&#8722;</sup>CD49d<sup>&#8722;</sup> cells in the CD11b<sup>+</sup>CD45<sup>dim</sup> population (population 6). Based on MHC&#8208;II, CCR2, and PD&#8208;L1 expression we identified three clusters of microglia with different activation states (6A, 6B, 6C). CD45<sup>+</sup>CD11b<sup>+</sup> infiltrating myeloid cells contain granulocytes (population 7), Ly6C<sup>hi</sup>CCR2<sup>hi</sup> recently extravasated monocytes (population 8), and some clusters of macrophages with different phenotypes and/or states of activation (9A, 9B, 9C, 9D, 9E, and 9F) based on their expression of CCR2, MHC&#8208;II, PD&#8208;L1, CD38, and CD88. Gated populations were identified based on two&#8208;dimensional embeddings of the high dimensional space visualized using the viSNE algorithm in Cytobank (Fig. <xref rid="cytoa23725-fig-0001" ref-type="fig">1</xref>B,C).</p><fig fig-type="Figure" xml:lang="en" id="cytoa23725-fig-0001" orientation="portrait" position="float"><label>Figure 1</label><caption><p>Identification of main leukocyte populations and CD45<sup>&#8722;</sup> cells in murine glioblastoma by manual gating and representation by viSNE. (<bold>A</bold>) Example gating of cell subsets. (<bold>B</bold>) viSNE embeddings color&#8208;coded for lineage markers. (<bold>C</bold>) Populations gated in A are color&#8208;coded according to the legend inset and displayed in the viSNE map. (<bold>D</bold>) Heatmap describing relative expression of lineage markers across the populations described in A, B, and C. (<bold>E</bold>) Heatmap displaying median mass intensity (ArcSinH(5)&#8208;transformed) of activation and migration markers across the populations described in A, B, and C.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" id="nlm-graphic-1" position="float" orientation="portrait" xlink:href="CYTO-95-422-g001.jpg"/></fig><p>Enzymatic digestions often result in the cleavage of molecules on the membrane of immune cells, which could have detrimental effect in their recognition by antibodies. In order to allow direct comparison amongst different organs (brain, spleen, and bone marrow) all samples were subjected to the same enzymatic treatment as it was required for the processing of the brain samples. The panel presented in this OMIP has been optimized to the single cell suspension preparation procedure as suggested by the manufacturer with some minor adjustments (see Supporting Information &#8220;Online Protocol&#8221;). Care should be taken to specifically address any effects of alterations in the tissue dissociation protocol to the performance of this panel.</p></sec><sec id="cytoa23725-sec-0003"><title>Similarity to Other OMIPs</title><p>This OMIP is partly overlapping with OMIP&#8208;032, which describes two murine multicolor immunofluorescence panels including the following markers to detect B and T lymphocytes, natural killer cells, dendritic cells, macrophages, monocytes, and neutrophils: CD45, TCR&#946;, CD4, CD8, Ly6C, CD49b, Ly6G, CD11c, MHCII, CD206, NKp46, CD62L, and CD44 <xref rid="cytoa23725-bib-0019" ref-type="ref">19</xref>. These markers overlap with our panel except for CD49b, NKp46, and CD62L. Since our panel is more focused on activation and exhaustion in T lymphocytes, we included more antibodies against activation markers and co&#8208;inhibitory molecules (immune checkpoints) rather than the presence of na&#239;ve or memory T cells. Also OMIP&#8208;031 has overlap with a panel aimed at immune checkpoint expression <xref rid="cytoa23725-bib-0020" ref-type="ref">20</xref>, which reports the following markers: CD3, CD4, CD8, CD69, CD44, CD45RA, CD27, CD62L, KLRG127, CD127, PD&#8208;1, CTLA4, TIM&#8208;3, LAG&#8208;3, and CD45. Our panel includes all of these markers except for CD45RA, CD27, CD62L, KLG127, and LAG&#8208;3. Previously, three other mass cytometry panels have been published. They focus on the characterization of human peripheral leukocytes (OMIP&#8208;34), human head and neck cancer (OMIP&#8208;45), and the quantification of calcium sensors and channels in lymphocyte subsets <xref rid="cytoa23725-bib-0021" ref-type="ref">21</xref>, <xref rid="cytoa23725-bib-0022" ref-type="ref">22</xref>, <xref rid="cytoa23725-bib-0023" ref-type="ref">23</xref>. This is the first mass cytometry OMIP for a comprehensive characterization of the mouse immune system. All data used generated during the optimization and verification of this panel can be found in FlowRepository under ID: FR&#8208;FCM&#8208;ZYUF.</p></sec><sec id="cytoa23725-sec-0005"><title>Author Contributions</title><p>SAD and JV performed experiments. SAD and JV developed and optimized the panel. SAD, JV, and JJGV discussed panel design and optimization. SAD and JJGV wrote the article. The authors declare that they have no conflict of interest.</p></sec><sec sec-type="supplementary-material"><title>Supporting information</title><supplementary-material content-type="local-data" id="cytoa23725-supitem-0001" position="float" orientation="portrait"><caption><p>
<bold>Appendix S1</bold> Supporting Information.</p></caption><media xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="CYTO-95-422-s001.docx" position="float" orientation="portrait"><caption><p>Click here for additional data file.</p></caption></media></supplementary-material></sec></body><back><ack id="cytoa23725-sec-0004"><title>Acknowledgments</title><p>We thank Prof. van Kooyk (Amsterdam UMC, Location VUmc) for fruitful discussions and laboratory resources. We also thank S. Schetters, Dr. Crommentuijn (both from Amsterdam UMC, Location VUmc), E. Abels (Massachusetts General Hospital), and Dr. Broekman (Leiden University Medical Center) for discussions and suggestions during panel design. We thank E. Abels for providing samples for optimization experiments.</p></ack><ref-list id="cytoa23725-bibl-0001" content-type="cited-references"><title>Literature Cited</title><ref id="cytoa23725-bib-0001"><label>1</label><mixed-citation publication-type="journal" id="cytoa23725-cit-0001"><string-name name-style="western"><surname>Zunder</surname><given-names>ER</given-names></string-name>, <string-name name-style="western"><surname>Finck</surname><given-names>R</given-names></string-name>, <string-name name-style="western"><surname>Behbehani</surname><given-names>GK</given-names></string-name>, <string-name name-style="western"><surname>Amir</surname><given-names>EAD</given-names></string-name>, <string-name name-style="western"><surname>Krishnaswamy</surname><given-names>S</given-names></string-name>, <string-name name-style="western"><surname>Gonzalez</surname><given-names>VD</given-names></string-name>, <string-name name-style="western"><surname>Lorang</surname><given-names>CG</given-names></string-name>, <string-name name-style="western"><surname>Bjornson</surname><given-names>Z</given-names></string-name>, <string-name name-style="western"><surname>Spitzer</surname><given-names>MH</given-names></string-name>, <string-name name-style="western"><surname>Bodenmiller</surname><given-names>B</given-names></string-name>, et al. <article-title>Palladium&#8208;based mass tag cell barcoding with a doublet&#8208;filtering scheme and single&#8208;cell deconvolution algorithm</article-title>. <source xml:lang="en">Nat Protoc</source><year>2015</year>;<volume>10</volume>:<fpage>316</fpage>&#8211;<lpage>333</lpage>.<pub-id pub-id-type="pmid">25612231</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/nprot.2015.020</pub-id><pub-id pub-id-type="pmcid">PMC4347881</pub-id></mixed-citation></ref><ref id="cytoa23725-bib-0002"><label>2</label><mixed-citation publication-type="journal" id="cytoa23725-cit-0002"><string-name name-style="western"><surname>Korin</surname><given-names>B</given-names></string-name>, <string-name name-style="western"><surname>Ben&#8208;Shaanan</surname><given-names>TL</given-names></string-name>, <string-name name-style="western"><surname>Schiller</surname><given-names>M</given-names></string-name>, <string-name name-style="western"><surname>Dubovik</surname><given-names>T</given-names></string-name>, <string-name name-style="western"><surname>Azulay&#8208;Debby</surname><given-names>H</given-names></string-name>, <string-name name-style="western"><surname>Boshnak</surname><given-names>NT</given-names></string-name>, <string-name name-style="western"><surname>Koren</surname><given-names>T</given-names></string-name>, <string-name name-style="western"><surname>Rolls</surname><given-names>A</given-names></string-name>. <article-title>High&#8208;dimensional, single&#8208;cell characterization of the brain's immune compartment</article-title>. <source xml:lang="en">Nat Neurosci</source><year>2017</year>;<volume>20</volume>:<fpage>1300</fpage>&#8211;<lpage>1309</lpage>. <pub-id pub-id-type="doi">10.1038/nn.4610</pub-id>.<pub-id pub-id-type="pmid">28758994</pub-id></mixed-citation></ref><ref id="cytoa23725-bib-0003"><label>3</label><mixed-citation publication-type="journal" id="cytoa23725-cit-0003"><string-name name-style="western"><surname>Ajami</surname><given-names>B</given-names></string-name>, <string-name name-style="western"><surname>Samusik</surname><given-names>N</given-names></string-name>, <string-name name-style="western"><surname>Wieghofer</surname><given-names>P</given-names></string-name>, <string-name name-style="western"><surname>Ho</surname><given-names>PP</given-names></string-name>, <string-name name-style="western"><surname>Crotti</surname><given-names>A</given-names></string-name>, <string-name name-style="western"><surname>Bjornson</surname><given-names>Z</given-names></string-name>, <string-name name-style="western"><surname>Prinz</surname><given-names>M</given-names></string-name>, <string-name name-style="western"><surname>Fantl</surname><given-names>WJ</given-names></string-name>, <string-name name-style="western"><surname>Nolan</surname><given-names>GP</given-names></string-name>, <string-name name-style="western"><surname>Steinman</surname><given-names>L</given-names></string-name>. <article-title>Single&#8208;cell mass cytometry reveals distinct populations of brain myeloid cells in mouse neuroinflammation and neurodegeneration models</article-title>. <source xml:lang="en">Nat Neurosci</source><year>2018</year>;<volume>21</volume>:<fpage>541</fpage>&#8211;<lpage>551</lpage>. <pub-id pub-id-type="doi">10.1038/s41593-018-0100-x</pub-id>.<pub-id pub-id-type="pmid">29507414</pub-id><pub-id pub-id-type="pmcid">PMC8629134</pub-id></mixed-citation></ref><ref id="cytoa23725-bib-0004"><label>4</label><mixed-citation publication-type="journal" id="cytoa23725-cit-0004"><string-name name-style="western"><surname>Mrdjen</surname><given-names>D</given-names></string-name>, <string-name name-style="western"><surname>Pavlovic</surname><given-names>A</given-names></string-name>, <string-name name-style="western"><surname>Hartmann</surname><given-names>FJ</given-names></string-name>, <string-name name-style="western"><surname>Schreiner</surname><given-names>B</given-names></string-name>, et al. <article-title>High&#8208;dimensional single&#8208;cell mapping of central nervous system immune cells reveals distinct myeloid subsets in health, aging, and disease</article-title>. <source xml:lang="en">Immunity</source><year>2018</year>;<volume>48</volume>:<fpage>380</fpage>&#8211;<lpage>395</lpage>.<pub-id pub-id-type="pmid">29426702</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.immuni.2018.01.011</pub-id></mixed-citation></ref><ref id="cytoa23725-bib-0005"><label>5</label><mixed-citation publication-type="journal" id="cytoa23725-cit-0005"><string-name name-style="western"><surname>Bowman</surname><given-names>RL</given-names></string-name>, <string-name name-style="western"><surname>Klemm</surname><given-names>F</given-names></string-name>, <string-name name-style="western"><surname>Akkari</surname><given-names>L</given-names></string-name>, <string-name name-style="western"><surname>Pyonteck</surname><given-names>SM</given-names></string-name>, <string-name name-style="western"><surname>Sevenich</surname><given-names>L</given-names></string-name>, <string-name name-style="western"><surname>Quail</surname><given-names>DF</given-names></string-name>, <string-name name-style="western"><surname>Dhara</surname><given-names>S</given-names></string-name>, <string-name name-style="western"><surname>Simpson</surname><given-names>K</given-names></string-name>, <string-name name-style="western"><surname>Gardner</surname><given-names>EE</given-names></string-name>, <string-name name-style="western"><surname>Iacobuzio&#8208;Donahue</surname><given-names>CA</given-names></string-name>, et al. <article-title>Macrophage ontogeny underlies differences in tumor&#8208;specific education in brain malignancies</article-title>. <source xml:lang="en">Cell Rep</source><year>2016</year>;<volume>17</volume>:<fpage>2445</fpage>&#8211;<lpage>2459</lpage>.<pub-id pub-id-type="pmid">27840052</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.celrep.2016.10.052</pub-id><pub-id pub-id-type="pmcid">PMC5450644</pub-id></mixed-citation></ref><ref id="cytoa23725-bib-0006"><label>6</label><mixed-citation publication-type="journal" id="cytoa23725-cit-0006"><string-name name-style="western"><surname>Chen</surname><given-names>Z</given-names></string-name>, <string-name name-style="western"><surname>Feng</surname><given-names>X</given-names></string-name>, <string-name name-style="western"><surname>Herting</surname><given-names>CJ</given-names></string-name>, <string-name name-style="western"><surname>Garcia</surname><given-names>VA</given-names></string-name>, <string-name name-style="western"><surname>Nie</surname><given-names>K</given-names></string-name>, <string-name name-style="western"><surname>Pong</surname><given-names>WW</given-names></string-name>, <string-name name-style="western"><surname>Rasmussen</surname><given-names>R</given-names></string-name>, <string-name name-style="western"><surname>Dwivedi</surname><given-names>B</given-names></string-name>, <string-name name-style="western"><surname>Seby</surname><given-names>S</given-names></string-name>, <string-name name-style="western"><surname>Wolf</surname><given-names>SA</given-names></string-name>, et al. <article-title>Cellular and molecular identity of tumor&#8208;associated macrophages in glioblastoma</article-title>. <source xml:lang="en">Cancer Res</source><year>2017</year>;<volume>77</volume>:<fpage>2266</fpage>&#8211;<lpage>2278</lpage>.<pub-id pub-id-type="pmid">28235764</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1158/0008-5472.CAN-16-2310</pub-id><pub-id pub-id-type="pmcid">PMC5741820</pub-id></mixed-citation></ref><ref id="cytoa23725-bib-0007"><label>7</label><mixed-citation publication-type="journal" id="cytoa23725-cit-0007"><string-name name-style="western"><surname>Bennett</surname><given-names>ML</given-names></string-name>, <string-name name-style="western"><surname>Bennett</surname><given-names>FC</given-names></string-name>, <string-name name-style="western"><surname>Liddelow</surname><given-names>SA</given-names></string-name>, <string-name name-style="western"><surname>Ajami</surname><given-names>B</given-names></string-name>, <string-name name-style="western"><surname>Zamanian</surname><given-names>JL</given-names></string-name>, <string-name name-style="western"><surname>Fernhoff</surname><given-names>NB</given-names></string-name>, <string-name name-style="western"><surname>Mulinyawe</surname><given-names>SB</given-names></string-name>, <string-name name-style="western"><surname>Bohlen</surname><given-names>CJ</given-names></string-name>, <string-name name-style="western"><surname>Adil</surname><given-names>A</given-names></string-name>, <string-name name-style="western"><surname>Tucker</surname><given-names>A</given-names></string-name>, et al. <article-title>New tools for studying microglia in the mouse and human CNS</article-title>. <source xml:lang="en">Proc Natl Acad Sci U S A</source><year>2016</year>;<volume>113</volume>:<fpage>E1738</fpage>&#8211;<lpage>E1746</lpage>.<pub-id pub-id-type="pmid">26884166</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1073/pnas.1525528113</pub-id><pub-id pub-id-type="pmcid">PMC4812770</pub-id></mixed-citation></ref><ref id="cytoa23725-bib-0008"><label>8</label><mixed-citation publication-type="journal" id="cytoa23725-cit-0008"><string-name name-style="western"><surname>Chen</surname><given-names>DS</given-names></string-name>, <string-name name-style="western"><surname>Mellman</surname><given-names>I</given-names></string-name>. <article-title>Oncology meets immunology: The cancer&#8208;immunity cycle</article-title>. <source xml:lang="en">Immunity</source><year>2013</year>;<volume>39</volume>:<fpage>1</fpage>&#8211;<lpage>10</lpage>.<pub-id pub-id-type="pmid">23890059</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.immuni.2013.07.012</pub-id></mixed-citation></ref><ref id="cytoa23725-bib-0009"><label>9</label><mixed-citation publication-type="journal" id="cytoa23725-cit-0009"><string-name name-style="western"><surname>Galluzzi</surname><given-names>L</given-names></string-name>, <string-name name-style="western"><surname>Vacchelli</surname><given-names>E</given-names></string-name>, <string-name name-style="western"><surname>Bravo&#8208;San Pedro</surname><given-names>JM</given-names></string-name>, et al. <article-title>Classification of current anticancer immunotherapies</article-title>. <source xml:lang="en">Oncotarget</source><year>2014</year>;<volume>5</volume>:<fpage>12472</fpage>&#8211;<lpage>12508</lpage>.<pub-id pub-id-type="pmid">25537519</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.18632/oncotarget.2998</pub-id><pub-id pub-id-type="pmcid">PMC4350348</pub-id></mixed-citation></ref><ref id="cytoa23725-bib-0010"><label>10</label><mixed-citation publication-type="journal" id="cytoa23725-cit-0010"><string-name name-style="western"><surname>Lim</surname><given-names>M</given-names></string-name>, <string-name name-style="western"><surname>Xia</surname><given-names>Y</given-names></string-name>, <string-name name-style="western"><surname>Bettegowda</surname><given-names>C</given-names></string-name>, <string-name name-style="western"><surname>Weller</surname><given-names>M</given-names></string-name>. <article-title>Current state of immunotherapy for glioblastoma</article-title>. <source xml:lang="en">Nat Rev Clin Oncol</source><year>2018</year>;<volume>15</volume>:<fpage>422</fpage>&#8211;<lpage>442</lpage>. <pub-id pub-id-type="doi">10.1038/s41571-018-0003-5</pub-id>.<pub-id pub-id-type="pmid">29643471</pub-id></mixed-citation></ref><ref id="cytoa23725-bib-0011"><label>11</label><mixed-citation publication-type="journal" id="cytoa23725-cit-0011"><string-name name-style="western"><surname>Maxwell</surname><given-names>R</given-names></string-name>, <string-name name-style="western"><surname>Jackson</surname><given-names>CM</given-names></string-name>, <string-name name-style="western"><surname>Lim</surname><given-names>M</given-names></string-name>. <article-title>Clinical trials investigating immune checkpoint blockade in Glioblastoma</article-title>. <source xml:lang="en">Curr Treat Options Oncol</source><year>2017</year>;<volume>18</volume>:<fpage>51</fpage>.<pub-id pub-id-type="pmid">28785997</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1007/s11864-017-0492-y</pub-id></mixed-citation></ref><ref id="cytoa23725-bib-0012"><label>12</label><mixed-citation publication-type="journal" id="cytoa23725-cit-0012"><string-name name-style="western"><surname>Wurdinger</surname><given-names>T</given-names></string-name>, <string-name name-style="western"><surname>Deumelandt</surname><given-names>K</given-names></string-name>, <string-name name-style="western"><surname>van der Vliet</surname><given-names>HJ</given-names></string-name>, <string-name name-style="western"><surname>Wesseling</surname><given-names>P</given-names></string-name>, <string-name name-style="western"><surname>de Gruijl</surname><given-names>TD</given-names></string-name>. <article-title>Mechanisms of intimate and long&#8208;distance cross&#8208;talk between glioma and myeloid cells: How to break a vicious cycle</article-title>. <source xml:lang="en">Biochim Biophys Acta Rev Cancer</source><year>2014</year>;<volume>1846</volume>:<fpage>560</fpage>&#8211;<lpage>575</lpage>.<pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.bbcan.2014.10.003</pub-id><pub-id pub-id-type="pmid">25453365</pub-id></mixed-citation></ref><ref id="cytoa23725-bib-0013"><label>13</label><mixed-citation publication-type="journal" id="cytoa23725-cit-0013"><string-name name-style="western"><surname>Broekman</surname><given-names>ML</given-names></string-name>, <string-name name-style="western"><surname>Maas</surname><given-names>SLN</given-names></string-name>, <string-name name-style="western"><surname>Abels</surname><given-names>ER</given-names></string-name>, <string-name name-style="western"><surname>Mempel</surname><given-names>TR</given-names></string-name>, <string-name name-style="western"><surname>Krichevsky</surname><given-names>AM</given-names></string-name>, <string-name name-style="western"><surname>Breakefield</surname><given-names>XO</given-names></string-name>. <article-title>Multidimensional communication in the microenvirons of glioblastoma</article-title>. <source xml:lang="en">Nat Rev Neurol</source><year>2018</year>;<volume>14</volume>:<fpage>482</fpage>&#8211;<lpage>495</lpage>. <pub-id pub-id-type="doi">10.1038/s41582-018-0025-8</pub-id>.<pub-id pub-id-type="pmid">29985475</pub-id><pub-id pub-id-type="pmcid">PMC6425928</pub-id></mixed-citation></ref><ref id="cytoa23725-bib-0014"><label>14</label><mixed-citation publication-type="journal" id="cytoa23725-cit-0014"><string-name name-style="western"><surname>Quail</surname><given-names>DF</given-names></string-name>, <string-name name-style="western"><surname>Joyce</surname><given-names>JA</given-names></string-name>. <article-title>The microenvironmental landscape of brain tumors</article-title>. <source xml:lang="en">Cancer Cell</source><year>2017</year>;<volume>31</volume>:<fpage>326</fpage>&#8211;<lpage>341</lpage>.<pub-id pub-id-type="pmid">28292436</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.ccell.2017.02.009</pub-id><pub-id pub-id-type="pmcid">PMC5424263</pub-id></mixed-citation></ref><ref id="cytoa23725-bib-0015"><label>15</label><mixed-citation publication-type="journal" id="cytoa23725-cit-0015"><string-name name-style="western"><surname>Hambardzumyan</surname><given-names>D</given-names></string-name>, <string-name name-style="western"><surname>Gutmann</surname><given-names>DH</given-names></string-name>, <string-name name-style="western"><surname>Kettenmann</surname><given-names>H</given-names></string-name>. <article-title>The role of microglia and macrophages in glioma maintenance and progression</article-title>. <source xml:lang="en">Nat Neurosci</source><year>2015</year>;<volume>19</volume>:<fpage>20</fpage>&#8211;<lpage>27</lpage>.<pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/nn.4185</pub-id><pub-id pub-id-type="pmcid">PMC4876023</pub-id><pub-id pub-id-type="pmid">26713745</pub-id></mixed-citation></ref><ref id="cytoa23725-bib-0016"><label>16</label><mixed-citation publication-type="journal" id="cytoa23725-cit-0016"><string-name name-style="western"><surname>Spitzer</surname><given-names>MH</given-names></string-name>, <string-name name-style="western"><surname>Nolan</surname><given-names>GP</given-names></string-name>. <article-title>Mass cytometry: Single cells, many features</article-title>. <source xml:lang="en">Cell</source><year>2016</year>;<volume>165</volume>:<fpage>780</fpage>&#8211;<lpage>791</lpage>.<pub-id pub-id-type="pmid">27153492</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.cell.2016.04.019</pub-id><pub-id pub-id-type="pmcid">PMC4860251</pub-id></mixed-citation></ref><ref id="cytoa23725-bib-0017"><label>17</label><mixed-citation publication-type="journal" id="cytoa23725-cit-0017"><string-name name-style="western"><surname>Hussain</surname><given-names>RZ</given-names></string-name>, <string-name name-style="western"><surname>Miller&#8208;Little</surname><given-names>WA</given-names></string-name>, <string-name name-style="western"><surname>Doelger</surname><given-names>R</given-names></string-name>, <string-name name-style="western"><surname>Cutter</surname><given-names>GR</given-names></string-name>, <string-name name-style="western"><surname>Loof</surname><given-names>N</given-names></string-name>, <string-name name-style="western"><surname>Cravens</surname><given-names>PD</given-names></string-name>, <string-name name-style="western"><surname>St&#252;ve</surname><given-names>O</given-names></string-name>. <article-title>Defining standard enzymatic dissociation methods for individual brains and spinal cords in EAE</article-title>. <source xml:lang="en">Neurol Neuroimmunol NeuroInflamm</source><year>2018</year>;<volume>5</volume>:<fpage>1</fpage>&#8211;<lpage>10</lpage>.<pub-id pub-id-type="doi" assigning-authority="pmc">10.1212/NXI.0000000000000437</pub-id><pub-id pub-id-type="pmcid">PMC5773844</pub-id><pub-id pub-id-type="pmid">29359175</pub-id></mixed-citation></ref><ref id="cytoa23725-bib-0018"><label>18</label><mixed-citation publication-type="journal" id="cytoa23725-cit-0018"><string-name name-style="western"><surname>Finck</surname><given-names>R</given-names></string-name>, <string-name name-style="western"><surname>Simonds</surname><given-names>EF</given-names></string-name>, <string-name name-style="western"><surname>Jager</surname><given-names>A</given-names></string-name>, <string-name name-style="western"><surname>Krishnaswamy</surname><given-names>S</given-names></string-name>, <string-name name-style="western"><surname>Sachs</surname><given-names>K</given-names></string-name>, <string-name name-style="western"><surname>Fantl</surname><given-names>W</given-names></string-name>, <string-name name-style="western"><surname>Pe'er</surname><given-names>D</given-names></string-name>, <string-name name-style="western"><surname>Nolan</surname><given-names>GP</given-names></string-name>, <string-name name-style="western"><surname>Bendall</surname><given-names>SC</given-names></string-name>. <article-title>Normalization of mass cytometry data with bead standards</article-title>. <source xml:lang="en">Cytometry Part A</source><year>2013</year>;<volume>83A</volume>:<fpage>483</fpage>&#8211;<lpage>494</lpage>.<pub-id pub-id-type="doi" assigning-authority="pmc">10.1002/cyto.a.22271</pub-id><pub-id pub-id-type="pmcid">PMC3688049</pub-id><pub-id pub-id-type="pmid">23512433</pub-id></mixed-citation></ref><ref id="cytoa23725-bib-0019"><label>19</label><mixed-citation publication-type="journal" id="cytoa23725-cit-0019"><string-name name-style="western"><surname>Unsworth</surname><given-names>A</given-names></string-name>, <string-name name-style="western"><surname>Anderson</surname><given-names>R</given-names></string-name>, <string-name name-style="western"><surname>Haynes</surname><given-names>N</given-names></string-name>, <string-name name-style="western"><surname>Britt</surname><given-names>K</given-names></string-name>. <article-title>OMIP&#8208;032: Two multi&#8208;color immunophenotyping panels for assessing the innate and adaptive immune cells in the mouse mammary gland</article-title>. <source xml:lang="en">Cytometry Part A</source><year>2016</year>;<volume>89A</volume>:<fpage>527</fpage>&#8211;<lpage>530</lpage>.<pub-id pub-id-type="doi" assigning-authority="pmc">10.1002/cyto.a.22867</pub-id><pub-id pub-id-type="pmid">27214375</pub-id></mixed-citation></ref><ref id="cytoa23725-bib-0020"><label>20</label><mixed-citation publication-type="journal" id="cytoa23725-cit-0020"><string-name name-style="western"><surname>Nemoto</surname><given-names>S</given-names></string-name>, <string-name name-style="western"><surname>Mailloux</surname><given-names>AW</given-names></string-name>, <string-name name-style="western"><surname>Kroeger</surname><given-names>J</given-names></string-name>, <string-name name-style="western"><surname>Mul&#233;</surname><given-names>JJ</given-names></string-name>. <article-title>OMIP&#8208;031: Immunologic checkpoint expression on murine effector and memory T&#8208;cell subsets</article-title>. <source xml:lang="en">Cytometry Part A</source><year>2016</year>;<volume>89A</volume>:<fpage>427</fpage>&#8211;<lpage>429</lpage>.<pub-id pub-id-type="doi" assigning-authority="pmc">10.1002/cyto.a.22808</pub-id><pub-id pub-id-type="pmcid">PMC4879048</pub-id><pub-id pub-id-type="pmid">26859685</pub-id></mixed-citation></ref><ref id="cytoa23725-bib-0021"><label>21</label><mixed-citation publication-type="journal" id="cytoa23725-cit-0021"><string-name name-style="western"><surname>Baumgart</surname><given-names>S</given-names></string-name>, <string-name name-style="western"><surname>Peddinghaus</surname><given-names>A</given-names></string-name>, <string-name name-style="western"><surname>Schulte&#8208;Wrede</surname><given-names>U</given-names></string-name>, <string-name name-style="western"><surname>Mei</surname><given-names>HE</given-names></string-name>, <string-name name-style="western"><surname>Gr&#252;tzkau</surname><given-names>A</given-names></string-name>. <article-title>OMIP&#8208;034: Comprehensive immune phenotyping of human peripheral leukocytes by mass cytometry for monitoring immunomodulatory therapies</article-title>. <source xml:lang="en">Cytometry Part A</source><year>2017</year>;<volume>91A</volume>:<fpage>34</fpage>&#8211;<lpage>38</lpage>.<pub-id pub-id-type="doi" assigning-authority="pmc">10.1002/cyto.a.22894</pub-id><pub-id pub-id-type="pmid">27362704</pub-id></mixed-citation></ref><ref id="cytoa23725-bib-0022"><label>22</label><mixed-citation publication-type="journal" id="cytoa23725-cit-0022"><string-name name-style="western"><surname>Brodie</surname><given-names>TM</given-names></string-name>, <string-name name-style="western"><surname>Tosevski</surname><given-names>V</given-names></string-name>, <string-name name-style="western"><surname>Medov&#225;</surname><given-names>M</given-names></string-name>. <article-title>OMIP&#8208;045: Characterizing human head and neck tumors and cancer cell lines with mass cytometry</article-title>. <source xml:lang="en">Cytometry Part A</source><year>2018</year>;<volume>93A</volume>:<fpage>406</fpage>&#8211;<lpage>410</lpage>.<pub-id pub-id-type="doi" assigning-authority="pmc">10.1002/cyto.a.23336</pub-id><pub-id pub-id-type="pmid">29648681</pub-id></mixed-citation></ref><ref id="cytoa23725-bib-0023"><label>23</label><mixed-citation publication-type="journal" id="cytoa23725-cit-0023"><string-name name-style="western"><surname>Jaracz&#8208;Ros</surname><given-names>A</given-names></string-name>, <string-name name-style="western"><surname>H&#233;mon</surname><given-names>P</given-names></string-name>, <string-name name-style="western"><surname>Krzysiek</surname><given-names>R</given-names></string-name>, <string-name name-style="western"><surname>Bachelerie</surname><given-names>F</given-names></string-name>, <string-name name-style="western"><surname>Schlecht&#8208;Louf</surname><given-names>G</given-names></string-name>, <string-name name-style="western"><surname>Gary&#8208;Gouy</surname><given-names>H</given-names></string-name>. <article-title>OMIP&#8208;048 MC: Quantification of calcium sensors and channels expression in lymphocyte subsets by mass cytometry</article-title>. <source xml:lang="en">Cytometry A</source><year>2018</year>;<volume>93</volume>:<fpage>681</fpage>&#8211;<lpage>684</lpage>.<pub-id pub-id-type="pmid">30080305</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1002/cyto.a.23504</pub-id></mixed-citation></ref></ref-list></back></article></pmc-articleset>